Log in

OTCMKTS:RNVARennova Health Stock Price, Forecast & News

-0.56 (-28.00 %)
(As of 08/4/2020 04:00 PM ET)
Today's Range
Now: $1.44
50-Day Range N/A
52-Week Range
Now: $1.44
Volume46,969 shs
Average Volume99.63 million shs
Market Capitalization$14.25 billion
P/E RatioN/A
Dividend YieldN/A
Rennova Health, Inc., together with its subsidiaries, provides a suite of healthcare related products and services to healthcare providers in the United States. The company operates in three segments: Laboratory Services, Supportive Software Solutions, and Decision Support and Informatics Operations. It provides toxicology, clinical pharmacogenetics, and esoteric testing services. The company also offers Advantage, a HIPAA compliant software; Clinlab, a Windows-based Web-enabled laboratory information management system; and Medical Mime, a suite of solutions, which include an optimized Electronic health records (EHR) for substance abuse and behavioral health providers, a dictation-based ambulatory EHR for physician practices, and advanced transcription services. In addition, it develops and markets interpretation and decision support solutions that enhance cancer diagnoses and treatment through actionable data analytics and reporting for oncologists and their patients. Rennova Health, Inc. was founded in 2005 and is headquartered in West Palm Beach, Florida.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.70 out of 5 stars

Industry, Sector and Symbol

Industry General medical & surgical hospitals
Current SymbolOTCMKTS:RNVA
Previous SymbolNASDAQ:RNVA



Sales & Book Value

Annual Sales$15.99 million
Book Value($0.01) per share


Net Income$-48,030,000.00
Net Margins-319.55%


Outstanding Shares9,898,940,000
Market Cap$14.25 billion
Next Earnings Date12/9/2020 (Estimated)
OptionableNot Optionable
-0.56 (-28.00 %)
(As of 08/4/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive RNVA News and Ratings via Email

Sign-up to receive the latest news and ratings for RNVA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Rennova Health (OTCMKTS:RNVA) Frequently Asked Questions

How has Rennova Health's stock been impacted by COVID-19 (Coronavirus)?

Rennova Health's stock was trading at $0.0001 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, RNVA stock has increased by 1,439,900.0% and is now trading at $1.44.
View which stocks have been most impacted by Coronavirus

When is Rennova Health's next earnings date?

Rennova Health is scheduled to release its next quarterly earnings announcement on Wednesday, December 9th 2020.
View our earnings forecast for Rennova Health

How were Rennova Health's earnings last quarter?

Rennova Health Inc (OTCMKTS:RNVA) released its earnings results on Tuesday, August, 14th. The company reported $250.00 EPS for the quarter. The business had revenue of $3.29 million for the quarter.
View Rennova Health's earnings history

When did Rennova Health's stock split? How did Rennova Health's stock split work?

Rennova Health shares reverse split on Monday, November 12th 2018. The 1-500 reverse split was announced on Thursday, November 8th 2018. The number of shares owned by shareholders was adjusted after the market closes on Friday, November 9th 2018. An investor that had 100 shares of Rennova Health stock prior to the reverse split would have 0 shares after the split.

Has Rennova Health been receiving favorable news coverage?

News headlines about RNVA stock have trended somewhat positive recently, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Rennova Health earned a coverage optimism score of 0.8 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the near future.
View the latest news about Rennova Health

Who are some of Rennova Health's key competitors?

What other stocks do shareholders of Rennova Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Rennova Health investors own include Neovasc (NVCN), Himax Technologies (HIMX), CytRx (CYTR), Precipio (PRPO), Biopharmx (BPMX), Delcath Systems (DCTHD), Heat Biologics (HTBX), Immune Pharmaceuticals (IMNP), Protalix Biotherapeutics (PLX) and 22nd Century Group (XXII).

Who are Rennova Health's key executives?

Rennova Health's management team includes the following people:
  • Mr. Seamus Lagan, Pres, CEO & Director (Age 50)
  • Ms. Marlene McLennan, Chief Financial Officer
  • Ms. Karen Taylor, Director of HR
  • Mr. Albert F. Lechner, Exec. VP of Sales - Rennova Health Technology Solutions
  • Mr. Sebastien Sainsbury, Company Sec.

What is Rennova Health's stock symbol?

Rennova Health trades on the OTCMKTS under the ticker symbol "RNVA."

How do I buy shares of Rennova Health?

Shares of RNVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Rennova Health's stock price today?

One share of RNVA stock can currently be purchased for approximately $1.44.

How big of a company is Rennova Health?

Rennova Health has a market capitalization of $14.25 billion and generates $15.99 million in revenue each year. Rennova Health employs 98 workers across the globe.

What is Rennova Health's official website?

The official website for Rennova Health is www.rennovahealth.com.

How can I contact Rennova Health?

Rennova Health's mailing address is 931 Village Boulevard Suite 905, West Palm Beach FL, 33409. The company can be reached via phone at 561-855-1626 or via email at [email protected]

This page was last updated on 8/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.